29,056 resources
By Version
By Authority
By Realm
Start Prev Rows 20600 - 20800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.175 | Contraception, Counseling | active | 2024-04 | us | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8031 | Decedent Birthplace (Country) | active | 2021-01 | us | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8032 | Decedent Resident (Country) | active | 2021-01 | us | oid | |||
| nictiz.fhir.nl.stu3.questionnaires | R3 | questionnaire-enable-operator | QuestionnaireItemOperator | draft | 3 | fhir | 2019-10 | nl | hl7 | fhir |
| hl7.terminology | R5 | v3-Currency | Currency | retired | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.970 | Case Investigation Status | active | 2008-01 | us | sct tho oid | |||
| eu.miabis.r4 | R4 | miabis-dataset-type-vs | dataset type Value Set | active | ||||||
| ch.fhir.ig.ch-crl | R4 | nkrs-icdo3histologicalgrade | NKRS - ICD-O-3 Histological Grade | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-topographymetastases | NKRS - Topography of Metastases | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-lymphaticinvasion | NKRS - Lymphatic Invasion | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-venousinvasion | NKRS - Venous Invasion | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-sentinellymphnodeassessment | NKRS - Sentinel Lymph Node Assessment | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-luganostaging | NKRS - Lugano Staging | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-diagnosticmethodsused | NKRS - Diagnostic Methods Used | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-cn | NKRS - cN | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-her2receptorstatus | NKRS - Her2 Receptor Status | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-issstaging | NKRS - ISS Staging | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-stjudemurphystaging | NKRS - St. Jude / Murphy Staging | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-serumtumourmarkers | NKRS - Serum Tumour Markers | active | 2022-02 | ch | hl7 | internal sct | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-tnmstagegroup | NKRS - TNM Stage Group | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-pn | NKRS - pN | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-cm | NKRS - cM | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-pm | NKRS - pM | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-hcg | NKRS - β-hCG | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-ldh | NKRS - LDH | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-methodfirstdetection | NKRS - Method of First Detection | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-diabetesmellitus | NKRS - Diabetes Mellitus | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-liverdisease | NKRS - Liver Disease | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-alphafetoprotein | NKRS - α-fetoprotein | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-typerecurrencetransformation | NKRS - Type of Recurrence/Transformation | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-msuffixofpt | NKRS - m-Suffix of pT | active | 2022-02 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-ct | NKRS - cT | active | 2022-02 | ch | hl7 | internal | ||
| signal.core.r4 | R4 | days-of-week | DaysOfWeek | normative | 5 | fhir | 2019-10 | us | hl7 | fhir |
| hl7.fhir.uv.extensions | R5 | concept-map-equivalence | Concept Map Equivalence Value Set | trial-use | 3 | fhir | 2023-01 | uv | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1043 | Specimen Quality (HL7) | active | 2008-01 | us | tho | |||
| kl.dk.fhir.gateway | R4 | DeliveryTypes | DeliveryTypes | active | 2024-10 | dk | ||||
| kl.dk.fhir.prevention | R4 | DeliveryTypes119 | DeliveryTypes | active | 2024-06 | dk | ||||
| kl.dk.fhir.rehab | R4 | DeliveryTypes140 | DeliveryTypes | active | 2024-10 | dk | ||||
| hl7.terminology | R5 | v3-EntityDeterminerDetermined | EntityDeterminerDetermined | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-EntityDeterminerDescribedQuantified | EntityDeterminerDescribedQuantified | retired | 2012-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ParticipationDestination | ParticipationDestination | active | 2014-03 | uv | hl7 | tho | ||
| Test.Training | R3 | CareConnect-DischargeDestination-1 | NHS Data Model and Dictionary Discharge Destination | draft | 2018-11 | hl7 | ||||
| hl7.terminology | R5 | v3-ActInvoiceDetailGenericCode | ActInvoiceDetailGenericCode | active | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3591 | Source of Payment Typology (PHDSC) | active | 2021-01 | us | ||||
| niceprofiling.v23q1 | R3 | NICE_LaboratoryTestResultCodelist | NICE Laboratory Test Results | active | loinc | |||||
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-representation-types | Representation Types | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit |
| hl7.fhir.uv.cpg | R4 | cpg-recommendation-direction-vs | CPG Recommendation Direction Value Set | active | cds | 2024-11 | uv | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.915 | Discharge Disposition (HL7) | active | 2021-01 | us | tho | |||
| accdr.fhir.ig.pkg | R4 | documentKOD | Document KOD | active | 2023-05 | loinc | ||||
| accdr.fhir.ig.pkg | R4 | documentRole | Document Role | active | 2023-05 | ca | national | loinc | ||
| accdr.fhir.ig.pkg | R4 | documentsetting | Document Setting | active | 2023-05 | loinc | ||||
| accdr.fhir.ig.pkg | R4 | documentSMD | Document SMD | active | 2023-05 | loinc | ||||
| accdr.fhir.ig.pkg | R4 | documentTOS | Document TOS | active | 2023-05 | ca | national | loinc | ||
| ihe.pcc.mpsc | R4 | Active.Advance.Directive.Finding.VS | Active Advanced Healthcare Directives Findings Value Set | draft | 2025-03 | uv | ihe | sct | ||
| hl7.terminology | R5 | v3-MaritalStatus | MaritalStatus | active | 2014-03 | uv | hl7 | tho | ||
| hl7.fhir.uv.emedicinal-product-info | R5 | doseForm | Dose Form | active | 2025-07 | uv | hl7 | fhir | ||
| hl7.fhir.us.Davinci-drug-formulary | R4 | usdf-DrugTierVS | Drug Tier VS | draft | 2020-01 | us | hl7 | fhir | ||
| hl7.fhir.us.davinci-drug-formulary | R4 | DrugTierVS | Drug tier of medication in health plan | trial-use | phx | 2025-02 | us | hl7 | fhir | |
| hl7.fhir.uv.genomics-reporting | R4 | functional-effect-vs | Functional Effect Value Set | trial-use | 2 | cg | 2025-06 | uv | hl7 | |
| bloodpressure | R4 | MeasurementSetting | Measurement Setting value set | active | 2024-04 | sct | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7153 | Estimated Time of Death No Labor Ongoing (NCHS) | active | 2014-01 | us | sct | |||
| hl7.fhir.fr.core | R4 | fr-core-vs-practitioner-role-exercice | FR Core ValueSet PractitionerRole Exercice | active | 2024-09 | fr | hl7 | |||
| hl7.terminology | R5 | v3-TransferActReason | TransferActReason | active | 2014-03 | uv | hl7 | tho | ||
| hl7.fhir.be.medication | R4 | BeMedicationExposureIntentVS | Medication exposure intent | active | 2025-07 | be | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.176 | Methotrexate Injection | active | 2024-04 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.169 | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.171 | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.170 | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | sct | ||
| ihe.pcc.mpsc | R4 | Physical.Finding.of.Eye.TargetSite.VS | Physical Finding of Eye Target Site Value Set | draft | 2025-03 | uv | ihe | sct | ||
| hl7.terminology | R5 | v3-ParticipationTargetLocation | ParticipationTargetLocation | active | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) | active | 2015-01 | us | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) | active | 2015-01 | us | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7360 | Discharge Disposition IP (NCHS) | active | 2014-12 | us | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) | active | 2015-01 | us | sct tho oid | |||
| ca.on.mi.pkg | R4 | mi-document-type | Medical Imaging Document Type | active | 2024-04 | ca | loinc | |||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-usage-context-type | eHealth Usage Context Type | active | 2020-11 | dk | tho | |||
| ca-on-dhdr-r4.v09 | R4 | prescriptiondrugform | PrescriptionDrugForm | active | ca | national | ||||
| ca.on.ehr.r4 | R4 | ValueSet-PharmaceuticalDoseFormCode | Pharmaceutical Dose Form Code | active | 1899-12 | ca | national | sct | ||
| hl7.terminology | R5 | citation-summary-style | Citation Summary Style | trial-use | 1 | cds | 2025-01 | uv | hl7 | tho |
| fhir.argonaut.scheduling | R3 | argo-slot-status | Argonaut Slot Status Codes | active | 2018-03 | us | hl7 | fhir | ||
| hl7.terminology | R5 | verificationresult-need | Need | active | pa | 2024-04 | uv | hl7 | tho | |
| dk.ehealth.sundhed.fhir.ig.core | R4 | participant-function | Participant Function | active | 2024-09 | dk | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.5.20.2 | USDA Subject Function | active | 2010-01 | us | oid | |||
| ca.on.oh.mha-pds | R4 | FunctionalCentreCode-vs | Functional Centre Code | active | 2022-08 | |||||
| nhsd.assets.stu3 | R3 | CareConnect-NHSDataDictionary-PersonStatedGender-1 | NHS Data Model and Dictionary Person Stated Gender Code | active | 2017-08 | hl7 | ||||
| nhsd.assets.stu3 | R3 | NHSDataDictionary-PersonStatedGender-1 | NHS Data Model and Dictionary Person Stated Gender Code | active | 2017-08 | hl7 | ||||
| fhir.r4.ukcore.stu3.currentbuild | R4 | UKCore-PersonStatedGenderCode | UK Core Person Stated Gender Code | retired | 2021-09 | us | hl7 | |||
| csiro.fhir.au.smartforms | R4 | administrative-gender | AdministrativeGender | normative | 5 | pa | 2019-10 | au | hl7 | fhir |
| Test.Training | R3 | CareConnect-AdministrativeGender-1 | Administrative Gender | draft | 5 | pc | 2017-04 | hl7 | fhir | |
| NHSDigital.FHIR.STU3 | R3 | CareConnect-AdministrativeGender-1 | Administrative Gender | active | 5 | pc | 2017-04 | hl7 | fhir | |
| hl7.fhir.us.vrdr | R4 | vrdr-administrative-gender-vs | Administrative Gender ValueSet | active | pher | 2024-10 | us | hl7 | fhir | |
| ca.on.oh-olis | R4 | olis-AdministrativeGender | AdministrativeGender | active | hl7 | fhir | ||||
| hl7.terminology | R5 | v3-AdministrativeGender | AdministrativeGender | active | 2014-03 | uv | hl7 | tho | ||
| ehealth4u.package | R4 | cyehr-vs-ehdsiadministrativegender | Cyprus EHR Value Set: eHDSI Administrative Gender | active | tho | |||||
| hl7.terminology | R5 | v3-ActRelationshipHasGeneralization | ActRelationshipHasGeneralization | active | 2014-03 | uv | hl7 | tho | ||
| ch.fhir.ig.ch-crl | R4 | nkrs-treatmentgoal | NKRS - Treatment Goal | active | 2022-02 | ch | hl7 | sct | ||
| hl7.fhir.uv.extensions.r3 | R3 | variable-handling | Evidence Variable Handling | trial-use | 5 | cds | 2020-12 | uv | hl7 | fhir |
| hl7.terminology | R5 | statistic-model-code | Statistic Model Code | trial-use | 1 | cds | 2025-01 | uv | hl7 | tho |
| ca.on.oh.mha-pds | R4 | vs-HighestLevelOfEducationAttained-v1 | Highest Level of Education Attained | active | 2022-08 | ca | hl7 | sct tho | ||
| ca.on.oh.mha.pds | R4 | educational-attainment | Educational Attainment | draft | ||||||
| ca.on.oh.mha-pds | R4 | ValueSet.encounter-identifier-system | EncounterIdentifierValueSet | active | 2022-08 | ca | hl7 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.patient-jhn-identifier-system | PatientJHNIdentifierSystem | active | 2022-08 | ca | hl7 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.patient-mrn-identifier-system | PatientMRNIdentifierSystem | active | 2022-08 | ca | hl7 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.patient-episode-of-care-identifier-system | EpisodeOfCareIdentifierValueSet | active | 2022-08 | ca | hl7 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.ServiceRequest-identifier-system | ServiceRequestIdentifierValueSet | active | 2022-08 | ca | hl7 | |||
| ca.healthpei.io.core | R4 | RouteOfAdmin | Route Of Administration | active | 2024-06 | ca | sct | |||
| hl7.fhir.us.ecr | R4 | us-ph-message-significance-category | US Public Health Message Significance Category | trial-use | 1 | pher | 2019-10 | us | hl7 | fhir |
| hl7.fhir.us.ph-library | R4 | us-ph-valueset-message-significance-category | US Public Health ValueSet - Message Significance Category | trial-use | 1 | inm | 2019-10 | us | hl7 | fhir |
| hl7.terminology | R5 | v3-FirstFillPharmacySupplyType | FirstFillPharmacySupplyType | active | 2014-03 | uv | hl7 | tho | ||
| ca.on.dhdr.r4.v4 | R4 | EncounterType | Encounter Type | active | 2019-02 | us | hl7 | |||
| hl7.terminology | R5 | measure-data-usage | MeasureDataUsage | active | 2 | cqi | 2024-04 | uv | hl7 | tho |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.135 | Bleeding at Critical Site | active | 2021-06 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.145 | Bleeding at Non Critical Site | active | 2025-02 | us | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.143 | Bleeding at Critical Site | active | 2021-06 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.125 | Bleeding at Non Critical Site | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.146 | Bleeding at Non Critical Site | active | 2021-06 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.144 | Bleeding at Critical Site | active | 2021-06 | us | hl7 | vsac | ||
| hl7.fhir.nz.cca | R4 | sact-treatment-intent-code | Treatment intent | active | 2020-11 | nz | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.12 | Opioid (Oral Tablets and Patches only) | active | 2019-12 | us | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.117.1.7.1.1 | Major Surgical Procedure | active | 2025-02 | us | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.1250 | Major Surgical Procedure | active | 2025-02 | us | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.11 | Care Experience Preferences Grouping | active | 2022-03 | us | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.9 | Treatment Intervention Preferences Grouping | active | 2024-03 | us | hl7 | vsac | ||
| hl7.terminology | R5 | v3-ActSubstanceAdministrationImmunizationCode | ActSubstanceAdministrationImmunizationCode | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-AdjudicatedWithAdjustments | AdjudicatedWithAdjustments | active | 2014-03 | uv | hl7 | tho | ||
| fhir.r4.wales.discovery | R4 | DataStandardsWales-JobRole | Data Standards Wales Job Role | retired | 2021-08 | us | hl7 | |||
| hl7.fhir.uv.phenomics-exchange | R4 | KaryotypicSex | Karyotypic sex value set | draft | cic | 2021-05 | uv | hl7 | fhir | |
| hl7.terminology | R5 | dose-rate-type | DoseAndRateType | draft | 1 | fhir | 2020-02 | uv | hl7 | tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7363 | Specialty Unit Type (NCHS) | active | 2014-12 | us | cdc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7364 | Type of clinic/location (NCHS) | active | 2014-12 | us | cdc | |||
| hl7.fhir.uv.extensions.r4b | R4B | device-specification-category | Device Specification Category | trial-use | 2 | oo | 2022-03 | uv | hl7 | fhir |
| hl7.terminology | R5 | v3-VaccineType | VaccineType | active | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) | active | 2015-01 | us | sct tho | |||
| hl7.fhir.uv.extensions.r3 | R3 | spdx-license | S P D X License | trial-use | 4 | fhir | 2020-12 | uv | hl7 | fhir |
| ch.fhir.ig.ch-term | R4 | ch-vacd-swissmedic-imunglobuline-vs | CH VACD Swissmedic Authorized Immunglobuline Codes | active | 2025-05 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-swissmedic-imunsera-vs | CH VACD Swissmedic Authorized Immunsera Codes | active | 2025-05 | ch | hl7 | internal | ||
| hl7.fhir.us.covid19library | R4 | state-codes-vs | State Codes Value Set | active | 2022-07 | us | hl7 | sct | ||
| hl7.fhir.ca.baseline | R4 | prescriptionmedicinalproduct | Prescription Medicinal Product | draft | 2025-05 | ca | hl7 | |||
| hl7.fhir.ca.baseline | R4 | prescriptiondrugform | Prescription Drug Form | draft | 2025-05 | ca | hl7 | |||
| hl7.fhir.uv.sdc | R4 | dex-mimetype | DEX mapping language mime types | informative | fhir | 2025-08 | uv | hl7 | ietf | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason | active | 2008-01 | us | sct tho oid | |||
| ch.fhir.ig.ch-term | R4 | ch-vacd-vaccines-snomedct-vs | CH VACD Snomed CT for VaccineCode | active | 2025-05 | ch | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-vaccines-vs | CH VACD Swissmedic code for VaccineCode | active | 2025-05 | ch | hl7 | sct | ||
| ch.fhir.ig.ch-term | R4 | snomedct-concept-viraldiseases-vs | Snomed CT Concept Viral Diseases | active | 2025-05 | ch | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3593 | Cause of Death (ICD-10) | draft | us | icd | ||||
| signal.core.r4 | R4 | questionnaire-dacods-living-situation | Questionnaire DACODS Living Situation | draft | 1 | pa | us | hl7 | ||
| hl7.terminology | R5 | v3-ParticipationOrigin | ParticipationOrigin | active | 2014-03 | uv | hl7 | tho | ||
| ihe.pcc.mpsc | R4 | Destination.Prearrival.Activation.Type.VS | Destination Prearrival Activation Type Value Set | draft | 2025-03 | uv | ihe | sct | ||
| ihe.pcc.mpsc | R4 | Physical.Finding.of.Lung.TargetSite.VS | Physical Finding of Lung Tartget Site Value Set | draft | 2025-03 | uv | ihe | sct | ||
| hl7.terminology | R5 | v3-VaccineManufacturer | VaccineManufacturer | active | 2014-03 | uv | hl7 | tho | ||
| hl7.fhir.us.vrdr | R4 | vrdr-death-certification-event-max-vs | Event Code for Death Certificate Composition - Max | active | pher | 2024-10 | us | hl7 | fhir sct | |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.4057 | Emergency Department Encounter | active | 2020-07 | us | hl7 | cpt | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-vs | Swiss Risks For Immunizations | active | 2025-05 | ch | hl7 | internal | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-medical-vs | Swiss Medical Risks For Immunizations | active | 2025-05 | ch | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) | active | 2010-01 | us | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) | active | 2010-01 | us | sct tho | |||
| Test.Training | R3 | CareConnect-AdmissionMethod-1 | NHS Data Model and Dictionary Admission Method | draft | 2018-11 | hl7 | ||||
| Test.Training | R3 | CareConnect-DischargeMethod-1 | NHS Data Model and Dictionary Discharge Method | draft | 2018-11 | hl7 | ||||
| hl7.fhir.us.breastcancer | R3 | oncology-LymphNodeClinicalMethodVS | BC LymphNodeClinicalMethodVS ValueSet | draft | 2018-08 | us | hl7 | sct | ||
| hl7.terminology | R5 | v3-xActFinancialProductAcquisitionCode | x_ActFinancialProductAcquisitionCode | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ActProductAcquisitionCode | ActProductAcquisitionCode | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | characteristic-method | CharacteristicMethod | draft | 1 | cds | 2020-02 | uv | hl7 | tho |
| hl7.fhir.us.breastcancer | R3 | oncology-BreastCancerDetectionVS | BC BreastCancerDetectionVS ValueSet | draft | 2018-08 | us | hl7 | sct | ||
| hl7.terminology | R5 | service-referral-method | ReferralMethod | active | 1 | pa | 2024-04 | uv | hl7 | tho |
| signal.core.r4 | R4 | service-referral-method | ReferralMethod | draft | 1 | pa | 2019-10 | us | hl7 | tho |
| hl7.fhir.uv.extensions | R5 | major-fhir-version | Major FHIR Versions | trial-use | 3 | fhir | 2025-08 | uv | hl7 | fhir |
| hl7-france-fhir.administrative | R4 | fr-practitioner-specialty | fr-practitioner-specialty | active | 5 | pc | 2019-12 | hl7 | ||
| hl7.fhir.fr.core | R4 | fr-core-vs-practitioner-specialty | FR Core ValueSet Practitioner specialty | informative | 5 | pc | 2024-09 | fr | hl7 | |
| hl7.fhir.us.davinci-pas | R4 | PASInformationChangeMode | PAS Information Change Mode Value Set | trial-use | 3 | fm | 2025-07 | us | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7277 | Transport Mode to Hospital (NCHS) | active | 2015-01 | us | sct | |||
| hl7.terminology | R5 | v3-RoleClassActiveMoiety | RoleClassActiveMoiety | active | 2014-03 | uv | hl7 | tho | ||
| hl7.fhir.us.breastcancer | R3 | oncology-MorphologyBehaviorVS | BC MorphologyBehaviorVS ValueSet | draft | 2018-08 | us | hl7 | sct | ||
| ca.on.oh-olis | R4 | patient-contactrelationship | Patient Contact Relationship | normative | 5 | pa | 2019-10 | hl7 | tho | |
| ca-on-covax.v1 | R4 | patientrelationship | Patient Relationship | active | tho | |||||
| hl7.fhir.us.breastcancer | R3 | oncology-DCISNuclearGradeVS | BC DCISNuclearGradeVS ValueSet | draft | 2018-08 | us | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.914 | Diagnosis Priority (HL7) | active | 2008-01 | us | tho | |||
| hl7.terminology | R5 | v3-BuildingNumber | BuildingNumber | active | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7830 | Observation Identifier V2 (IIS) | active | 2018-01 | us | loinc | |||
| hl7.terminology | R5 | v3-ObservationInterpretationOustsideThreshold | ObservationInterpretationOustsideThreshold | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ObservationInterpretationProtocolInclusion | ObservationInterpretationProtocolInclusion | active | 2014-03 | uv | hl7 | tho | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-risks-occupation-vs | Swiss Occupation Risks For Immunizations | active | 2025-05 | ch | hl7 | internal sct | ||
| hl7.fhir.uv.extensions.r4b | R4B | device-operation-mode | FHIR Device Operation Mode | trial-use | 2 | oo | 2022-03 | uv | hl7 | fhir |
| silfhirprofileig | R5 | sghi-procedure-outcome | SGHI Procedure outcome value set | draft | 2025-07 | internal | ||||
| ng.gov.nphcda.immunization | R4 | nigeria-clinical-status | NG-Imm Clinical Status VS | active | 2025-08 | internal | ||||
| hl7.fhir.uv.cardx-cied | R5 | cied-connectivity-state-vs | CIED Connectivity Status Value Set | trial-use | 2 | cic | 2025-07 | uv | hl7 | fhir |
| ng.gov.nphcda.immunization | R4 | nigeria-location-owner | NG-Imm Location Owner | active | 2025-08 | internal | ||||
| ch.fhir.ig.ch-crl | R4 | nkrs-irssstaging | NKRS - IRSS Staging | active | 2022-02 | ch | hl7 | internal | ||
| ca.infoway.io.psca | R4 | immunizationrouteofadministrationcode | Immunization Route Of Administration Code | draft | 1899-12 | ca | national | |||
| hl7.terminology | R5 | v3-RouteOfAdministration | RouteOfAdministration | active | 2014-03 | uv | hl7 | tho | ||
| hl7.fhir.us.breastcancer | R3 | oncology-LymphNodeInvolvementVS | BC LymphNodeInvolvementVS ValueSet | draft | 2018-08 | us | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.998 | HIV Status | active | 2008-01 | us | sct tho oid | |||
| hl7.fhir.uv.extensions | R5 | patient-unknownIdentity | Patient's/person's identity is known/unknown | draft | pa | 2025-08 | uv | hl7 | fhir | |
| hl7.terminology | R5 | v3-ParticipationReceiver | ParticipationReceiver | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ParticipationResponsibleParty | ParticipationResponsibleParty | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-ParticipationReferredTo | ParticipationReferredTo | active | 2014-03 | uv | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) | active | 2019-01 | us | cdc sct tho | |||
| hl7.fhir.nz.cca | R4 | sact-administration-site-code | Administration location | active | 2020-11 | nz | hl7 | sct | ||
| hl7.fhir.nz.cca | R4 | sact-location-medication-collection-code | Medication collection location | active | 2020-11 | nz | hl7 | sct | ||
| hl7.terminology | R5 | v3-NaturalSibling | NaturalSibling | active | 2014-03 | uv | hl7 | tho | ||
| hl7.terminology | R5 | v3-NieceNephew | NieceNephew | active | 2014-03 | uv | hl7 | tho |
FHIR